Publications by authors named "Rick Chapman"

Claim this Profile
E
Evaluation of the Cost-effectiveness of Drug Treatment for Alzheimer Disease in a Simulation Model That Includes Caregiver and Societal Factors.
Kouta Ito, Rick Chapman, Steven D Pearson, Ali Tafazzoli, Kristine Yaffe

JAMA Netw Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on "Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States".
R Brett McQueen, Melanie D Whittington, Rick H Chapman, Varun M Kumar, Jonathan D Campbell

Pharmacoeconomics· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Evaluation of Dupilumab for Moderate-to-Severe Atopic Dermatitis: A Cost-Utility Analysis.
Marita Zimmermann, David Rind, Rick Chapman, Varun Kumar, Sonya Kahn

J Drugs Dermatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis.
Sumeyye Samur, Matthew Klebanoff, Reiner Banken, Daniel S Pratt, Rick Chapman

Hepatology· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis